# Using Polyglycolic Acid Mesh Prevents Cerebrospinal Fluid Leakage

> **NCT06472505** · NA · RECRUITING · sponsor: **National Taiwan University Hospital** · enrollment: 30 (estimated)

## Conditions studied

- Pituitary Tumor
- Cerebrospinal Fluid Leakage

## Interventions

- **DEVICE:** polyglycolic acid(Neoveil)

## Key facts

- **NCT ID:** NCT06472505
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-12-01
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2024-06-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06472505

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06472505, "Using Polyglycolic Acid Mesh Prevents Cerebrospinal Fluid Leakage". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06472505. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*